Rekombinanter ErbB2/Her2 (Trastuzumab Biosimilar) Antikörper
-
- Target Alle ErbB2/Her2 (Trastuzumab Biosimilar) Produkte
- ErbB2/Her2 (Trastuzumab Biosimilar)
- Antikörpertyp
- Recombinant Antibody
- Reaktivität
- Human
-
Wirt
-
Humanized
- Expressionssystem
- Mammalian cells
-
Klonalität
- Chimeric
-
Konjugat
- Dieser ErbB2/Her2 (Trastuzumab Biosimilar) Antikörper ist unkonjugiert
- Applikation
- Bitte anfragen
- Verwendungszweck
- Research Grade Trastuzumab Biosimilar Antibody
- Spezifität
- P185erbB2, HER2, NGL, Tyrosine kinase-type cell surface receptor HER2, NEU, MLN 19, Proto-oncogene Neu, MLN19, ERBB2, Proto-oncogene c-ErbB-2, CD340, Receptor tyrosine-protein kinase erbB-2, Metastatic lymph node gene 19 protein
- Aufreinigung
- Protein A or G purified from cell culture supernatant.
- Reinheit
- >95 % by SDS-PAGE.
- Güteklasse
- Research Grade
- Isotyp
- IgG1 kappa
-
anti-ErbB2/Her2 (Trastuzumab Biosimilar) antibody
Research Grade Reaktivität: Human FACS, ELISA Wirt: Humanized Monoclonal unconjugated Recombinant Antibody
anti-ErbB2/Her2 (Trastuzumab Biosimilar) antibodyReaktivität: Human FACS, ELISA, IHC Wirt: Kaninchen Chimeric 4D5-8 unconjugated Recombinant Antibody
-
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Konzentration
- 2.6 mg/mL
- Buffer
- 0.01M PBS, pH 7.4.
- Lagerung
- 4 °C,-20 °C,-80 °C
- Informationen zur Lagerung
- Use a manual defrost freezer and avoid repeated freeze-thaw cycles.Store at +4°C short term (1-2 weeks).Store at -20 °C 12 months. Store at -80°C long term.
- Haltbarkeit
- 12 months
-
- Target
- ErbB2/Her2 (Trastuzumab Biosimilar)
- Andere Bezeichnung
- Trastuzumab Biosimilar (ErbB2/Her2 (Trastuzumab Biosimilar) Produkte)
- Substanzklasse
- Biosimilar
- Hintergrund
- P185erbB2, HER2, NGL, Tyrosine kinase-type cell surface receptor HER2, NEU, MLN 19, Proto-oncogene Neu, MLN19, ERBB2, Proto-oncogene c-ErbB-2, CD340, Receptor tyrosine-protein kinase erbB-2, Metastatic lymph node gene 19 protein
- UniProt
- P04626
- CAS-Nummer
- 180288-69-1
-
